Mark Bertolini Acquires 1,000,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini acquired 1,000,000 shares of the firm’s stock in a transaction on Monday, April 6th. The stock was bought at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at $121,546,761.92. This represents a 10.87% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Oscar Health Stock Performance

Shares of OSCR stock opened at $14.63 on Thursday. The stock has a market capitalization of $4.36 billion, a PE ratio of -8.41 and a beta of 1.93. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $23.80. The stock’s 50-day moving average price is $13.12 and its 200 day moving average price is $15.73. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). The firm had revenue of $2.81 billion during the quarter, compared to analyst estimates of $3.12 billion. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. Oscar Health’s revenue for the quarter was up 17.3% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.62) EPS. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health News Roundup

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: CEO Mark Bertolini bought 1,000,000 shares at an average price of $11.92 (≈$11.92M), increasing his stake to ~10.2M shares — a sizeable vote of confidence that traders interpreted as bullish and is the main catalyst for today’s rally. Oscar Health (NYSE:OSCR) CEO Mark Bertolini Acquires 1,000,000 Shares Did Oscar Health’s CEO Just Cast a $12 Million Vote of Confidence?
• Neutral Sentiment: The timing coincides with upcoming company activity (Q1 earnings / investor call), which can amplify moves from an insider purchase but leaves direction dependent on the print and commentary. Oscar Health, Inc. 2026 First Quarter Earnings Conference Call
• Neutral Sentiment: Media and pundits are flagging the trade as a classic insider “vote of confidence” (citing Peter Lynch), which can attract momentum buyers but does not guarantee improved fundamentals. Did Oscar Health’s CEO Just Cast a $12 Million Vote of Confidence?
• Negative Sentiment: Underlying fundamentals remain mixed: Oscar reported an EPS miss and revenue shortfall in its last quarter and still shows negative margins and a negative ROE — these issues can limit sustained upside if future results don’t improve. SEC Form 4 / Filings
• Negative Sentiment: Analyst coverage is mixed (consensus “Hold”, average target ~ $16.88); multiple hold/sell ratings mean limited analyst-driven upward pressure unless guidance or results surprise positively. Oscar Health Analyst Coverage and Data

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research note on Thursday, January 22nd. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a research note on Thursday, February 12th. Stephens assumed coverage on shares of Oscar Health in a research note on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Finally, UBS Group reissued a “neutral” rating and set a $15.00 price objective on shares of Oscar Health in a research note on Wednesday, February 11th. Two analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $16.88.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds have recently made changes to their positions in the stock. Thrive Capital Management LLC lifted its holdings in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Baird Financial Group Inc. acquired a new position in shares of Oscar Health during the 1st quarter valued at $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Oscar Health by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after acquiring an additional 8,879 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Oscar Health by 39.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock valued at $6,169,000 after acquiring an additional 132,149 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.